Possibilities of non-viral gene transfer to improve cutaneous wound healing.

M. G. Jeschke, David Herndon, W. Baer, R. E. Barrow, K. W. Jauch

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Enhancement of dermal and epidermal regeneration represents a crucial goal for the treatment of acute, e.g. burn and trauma wounds, and chronic wounds, e.g. diabetic, autoimmune, arterial and venous wounds. Studies defining molecular mechanisms of the complex cascade of wound healing have shown that growth factors represent a new therapeutic strategy. The clinical application of growth factors in the form of proteins has been shown to be of little benefit. Therefore new delivery systems and therapeutic strategies needed to be developed to improve dermal and epidermal regeneration, one of which is gene therapy. For successful gene delivery the selection of an appropriate vector has been shown to be paramount. Because Retroviruses, Adenoviruses and Adeno-Associated Viruses can cause immunologic reactions and mutations, non-viral delivery systems for gene therapy, such as liposomal gene transfer appear advantageous over viral gene therapy. This review discusses the success, potential and limitations of non-viral gene transfer to improve regeneration of dermal and epidermal structures.

Original languageEnglish (US)
Pages (from-to)267-278
Number of pages12
JournalCurrent Gene Therapy
Volume1
Issue number3
StatePublished - Sep 2001
Externally publishedYes

Fingerprint

Wound Healing
Genetic Therapy
Regeneration
Skin
Wounds and Injuries
Genes
Intercellular Signaling Peptides and Proteins
Dependovirus
Viral Genes
Retroviridae
Adenoviridae
Therapeutics
Mutation
Proteins

ASJC Scopus subject areas

  • Genetics

Cite this

Jeschke, M. G., Herndon, D., Baer, W., Barrow, R. E., & Jauch, K. W. (2001). Possibilities of non-viral gene transfer to improve cutaneous wound healing. Current Gene Therapy, 1(3), 267-278.

Possibilities of non-viral gene transfer to improve cutaneous wound healing. / Jeschke, M. G.; Herndon, David; Baer, W.; Barrow, R. E.; Jauch, K. W.

In: Current Gene Therapy, Vol. 1, No. 3, 09.2001, p. 267-278.

Research output: Contribution to journalArticle

Jeschke, MG, Herndon, D, Baer, W, Barrow, RE & Jauch, KW 2001, 'Possibilities of non-viral gene transfer to improve cutaneous wound healing.', Current Gene Therapy, vol. 1, no. 3, pp. 267-278.
Jeschke MG, Herndon D, Baer W, Barrow RE, Jauch KW. Possibilities of non-viral gene transfer to improve cutaneous wound healing. Current Gene Therapy. 2001 Sep;1(3):267-278.
Jeschke, M. G. ; Herndon, David ; Baer, W. ; Barrow, R. E. ; Jauch, K. W. / Possibilities of non-viral gene transfer to improve cutaneous wound healing. In: Current Gene Therapy. 2001 ; Vol. 1, No. 3. pp. 267-278.
@article{4f9de516e4fb4890bfe360ac4a91de54,
title = "Possibilities of non-viral gene transfer to improve cutaneous wound healing.",
abstract = "Enhancement of dermal and epidermal regeneration represents a crucial goal for the treatment of acute, e.g. burn and trauma wounds, and chronic wounds, e.g. diabetic, autoimmune, arterial and venous wounds. Studies defining molecular mechanisms of the complex cascade of wound healing have shown that growth factors represent a new therapeutic strategy. The clinical application of growth factors in the form of proteins has been shown to be of little benefit. Therefore new delivery systems and therapeutic strategies needed to be developed to improve dermal and epidermal regeneration, one of which is gene therapy. For successful gene delivery the selection of an appropriate vector has been shown to be paramount. Because Retroviruses, Adenoviruses and Adeno-Associated Viruses can cause immunologic reactions and mutations, non-viral delivery systems for gene therapy, such as liposomal gene transfer appear advantageous over viral gene therapy. This review discusses the success, potential and limitations of non-viral gene transfer to improve regeneration of dermal and epidermal structures.",
author = "Jeschke, {M. G.} and David Herndon and W. Baer and Barrow, {R. E.} and Jauch, {K. W.}",
year = "2001",
month = "9",
language = "English (US)",
volume = "1",
pages = "267--278",
journal = "Current Gene Therapy",
issn = "1566-5232",
publisher = "Bentham Science Publishers B.V.",
number = "3",

}

TY - JOUR

T1 - Possibilities of non-viral gene transfer to improve cutaneous wound healing.

AU - Jeschke, M. G.

AU - Herndon, David

AU - Baer, W.

AU - Barrow, R. E.

AU - Jauch, K. W.

PY - 2001/9

Y1 - 2001/9

N2 - Enhancement of dermal and epidermal regeneration represents a crucial goal for the treatment of acute, e.g. burn and trauma wounds, and chronic wounds, e.g. diabetic, autoimmune, arterial and venous wounds. Studies defining molecular mechanisms of the complex cascade of wound healing have shown that growth factors represent a new therapeutic strategy. The clinical application of growth factors in the form of proteins has been shown to be of little benefit. Therefore new delivery systems and therapeutic strategies needed to be developed to improve dermal and epidermal regeneration, one of which is gene therapy. For successful gene delivery the selection of an appropriate vector has been shown to be paramount. Because Retroviruses, Adenoviruses and Adeno-Associated Viruses can cause immunologic reactions and mutations, non-viral delivery systems for gene therapy, such as liposomal gene transfer appear advantageous over viral gene therapy. This review discusses the success, potential and limitations of non-viral gene transfer to improve regeneration of dermal and epidermal structures.

AB - Enhancement of dermal and epidermal regeneration represents a crucial goal for the treatment of acute, e.g. burn and trauma wounds, and chronic wounds, e.g. diabetic, autoimmune, arterial and venous wounds. Studies defining molecular mechanisms of the complex cascade of wound healing have shown that growth factors represent a new therapeutic strategy. The clinical application of growth factors in the form of proteins has been shown to be of little benefit. Therefore new delivery systems and therapeutic strategies needed to be developed to improve dermal and epidermal regeneration, one of which is gene therapy. For successful gene delivery the selection of an appropriate vector has been shown to be paramount. Because Retroviruses, Adenoviruses and Adeno-Associated Viruses can cause immunologic reactions and mutations, non-viral delivery systems for gene therapy, such as liposomal gene transfer appear advantageous over viral gene therapy. This review discusses the success, potential and limitations of non-viral gene transfer to improve regeneration of dermal and epidermal structures.

UR - http://www.scopus.com/inward/record.url?scp=0035453245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035453245&partnerID=8YFLogxK

M3 - Article

VL - 1

SP - 267

EP - 278

JO - Current Gene Therapy

JF - Current Gene Therapy

SN - 1566-5232

IS - 3

ER -